NCT00086320View on ClinicalTrials.gov

A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.

PHASE3CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

August 31, 2005

Conditions
Schizophrenia
Interventions
DRUG

Paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00086320 - A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia. | Biotech Hunter | Biotech Hunter